Semaglutide prescription initiation predictors included female sex and use of antidepressants among patients with obesity without diabetes.

A clinical trial shows that people who were considered by medical researchers to report signs of alcohol use disorder drank significantly less after taking semaglutide for two months, compared to ...

Research reveals semaglutide's effectiveness in decreasing alcohol consumption and cravings, highlighting its potential for treating alcohol use disorder.

The FDA has approved Ozempic (semaglutide) to reduce the risk of kidney disease worsening and cardiovascular death in those with T2D and CKD.

Researchers at the University of North Carolina found that a once-weekly injection of Ozempic could cut cravings at its ...

Semaglutide, a medication widely used for diabetes and weight loss, may offer another unexpected benefit -- it could help ...

Compounded weight-loss medications, such as those promoted in the Hims & Hers commercial, aren’t approved by the Food and Drug Administration.

However, the extent of these benefits varies depending on the specific medication, dosage, and additional ... Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as ...

Female sex, antidepressant use, and type of health insurance significantly influence semaglutide initiation. HealthDay News — Sociodemographic, health care, and clinical factors are associated with ...

Humira®, manufactured by AbbVie, is again at the top of the list and semaglutide (Ozempic® and ... account for 54% of total drug spending in the U.S., according to IQVIA. Humira®, STELARA ...